The single-breath transfer factor for carbon monoxide and respiratory symptoms in a Norwegian community sample

European Respiratory Journal

Volumn 14, Issue 6, 1999, Pages 1320-1325

  Welle, I ^a   Eide, G E ^a   Bakke, P S ^a   Gulsvik, A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Breathlessness; Community survey; Epidemiology; Respiratory symptoms; Single breath transfer factor of the lung

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SELF REPORT; SEX DIFFERENCE; SMOKING HABIT; SPIROMETRY;

EID: 0033402784     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.14613209     Document Type: Article

References (27)

1. Thurlbeck W. Chronic airflow obstruction in lung disease. Philadelphia: Saunders WB; 1976.
2. Tukiainen P, Taskinen E, Holsti P, Korhola O, et al. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983; 38: 349-355.
3. Herbert S, Weill H, Stuckey W, Urner C, et al. Pulmonary diffusing capacity in polycythemic states before and after phlebotomy. Chest 1965; 48: 408-415.
4. Lipscomb D, Patel K, Hugues J. Interpretation of increase in the transfer coefficient for carbon monoxide (TL,CO/VA or KCO). Thorax 1978; 33: 728-733.
5. Cotes JE, Chinn DJ, Quanjer PH, Roca J, et al. Standardisation of the measurement of transfer factor (diffusing capacity). Report of working party. Standardisation of lung function tests, 1993 update. Eur Respir J 1993; 6: Suppl. 16, 41-52.
6. Cotes JE, Chinn DJ, Reed JW. Lung function testing: methods and reference values for forced expiratory volume and transfer factor. Occup Environ Med 1997; 54: 457-465.
7. Paoletti P, Viegi G, Pistelli G. Reference equations for the single-breath diffusing capacity. Am Rev Respir Dis 1985; 132: 806-813.
8. Teculescu D, Stanescu D. Lung diffusing capacity. Normal values in male smokers using the breath-holding technique. Scand J Respir Dis 1970; 51: 137-149.
9. Viegi G, Paoletti P, Prediletto R, Di Pede F, et al. Carbon monoxide diffusing capacity, other indices of lung function, and respiratory symptoms in a general population sample. Am Rev Respir Dis 1990; 141: 1033-1039.
10. Bakke P, Eide GE, Hanoa R, Gulsvik A. Occupational dust or gas exposure and prevalences of respiratory symptoms and asthma in a general population. Eur Respir J 1991; 4: 273-278.
11. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991; 46: 863-870.
12. Gulsvik A, Bakke P, Humerfelt S, Omenaas E, et al. Measurements of respiratory symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease. Eur Respir Rev 1991; 1: 436-443.
13. Bjartveit K, Foss O, Gjervig T. The cardiovascular diseases in Norwegian counties. Acta Med Scand 1983; 675: Suppl. 1: 1-184.
14. Gulsvik A, Bakke P, Humerfelt S, Omenaas E, et al. Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax 1992; 47: 167-173.
15. Welle I, Eide GE, Bakke P, Gulsvik A. Applicability of the single-breath carbon monoxide diffusing capacity in a Norwegian community study. Am J Respir Crit Care Med 1998; 158: 1745-1750.
16. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique - 1995 update. Am J Respir Crit Care Med 1995; 152: 2185-2198.
17. Jones RS, Meade F. A theoretical and experimental analysis of anomalities in the estimation of pulmonary diffusing capacity by the single-breath method. Q J Exp Physiol 1961; 46: 131-143.
18. ECCS. European Community for Coal and Steel. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19: Suppl. 5, 1-95.
19. Gulsvik A. Prevalence and manifestations of obstructive lung disease in the city of Oslo. Scand J Respir Dis 1979; 60: 286-296.
20. Dixon WJ. BMDP statistical software manual. Berkeley: University of California Press; 1985.
21. Siegel JL, Miller A, Brown LK, Deluca A, et al. Pulmonary diffusing capacity in left ventricular dysfunction. Chest 1990; 98: 550-553.
22. Macintyre N. Diffusing capacity of the lung for carbon monoxide. Respir Care Clin N Am 1997; 3: 221-233.
23. Stewart RI. Carbon monoxide diffusing capacity in asthmatic patients with mild airflow limitation. Chest 1988; 94: 332-336.
24. Boezen H, Schouten J, Postma D, Rijken B. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults. Thorax 1995; 50: 121-126.
25. Fletcher CM, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema. An eight-year study of early chronic obstructive lung disease in working men in London. Oxford: Oxford University Press; 1976.
26. Kauffmann F, Becklake M. Maladies respiratoires obstructives. Un paradigme de la complexité des differences de santé entre femmes et hommes. In: Saurel-Cubizolles M, Blondel B, eds. La santé des femmes. Paris: Flammarion, 1996. pp. 209-228.
27. Viegi G, Paoletti P, Vellutini M, Carrozi L, et al. Effects of daily cigarette consumption on respiratory symptoms and lung function in a general population sample of North-Italian men. Respiration 1991; 58: 282-286.